ホーム › 肝臓がん（肝細胞がん） › ミシガン州
ミシガン州における肝臓がん（肝細胞がん）の臨床試験
ミシガン州内の拠点で、肝臓がん（肝細胞がん）に関する20件の研究が参加者を募集しています。
ミシガン州内の都市
公式研究テキスト（英語）
The Vanguard Study: Testing a New Way to Screen for Cancer
- Henry Ford Cancer Institute-Downriver, Brownstown
- Henry Ford Health Center - Brownstown, Brownstown
- Henry Ford Health Center - Chesterfield, Chesterfield
- 他13件
被験者募集中健康なボランティア歓迎
45歳〜75歳 · 全性別 · 2026/10/05更新 · NCT06995898A Study of ZW251 in Participants With Advanced Solid Tumors
- START Midwest, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/05更新 · NCT07164313Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #65, Detroit
- Exelixis Clinical Site #13, Detroit
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483National Liver Cancer Screening Trial
- University of Michigan, Ann Arbor
- Henry Ford Health System, Detroit
被験者募集中第4相
18歳〜85歳 · 全性別 · 2026/09/25更新 · NCT06084234A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
- Local Institution - 0134, Detroit
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07291076Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
- Karmanos Cancer Institute, Detroit
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT06915753Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
- Henry Ford Health, Detroit
- University of Michigan Health - West, Wyoming
被験者募集中観察研究
22歳以上 · 全性別 · 2026/09/11更新 · NCT06486454Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- Research Site, Detroit
- Research Site, Grand Rapids
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06921785Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- C S Mott Children's Hospital, Ann Arbor
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/08/25更新 · NCT04851119Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
- Henry Ford Cancer Institute-Downriver, Brownstown
- Henry Ford Medical Center-Fairlane, Dearborn
- Henry Ford Hospital, Detroit
- 他4件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT07166406A Study of MGC026 in Participants With Advanced Solid Tumors
- START Midwest, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/11更新 · NCT06242470Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
- Michigan Cancer Research Consortium NCORP, Ann Arbor
- University of Michigan Comprehensive Cancer Center, Ann Arbor
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/04更新 · NCT05168163A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Karmanos Cancer Institute, Detroit
- Karmanos Cancer Institute, Farmington Hills
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/22更新 · NCT05208762CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules
- University of Michigan, Ann Arbor
被験者募集中
18歳以上 · 全性別 · 2026/07/02更新 · NCT06184152A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
- Clinical Trial Site, Ann Arbor
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/17更新 · NCT06600321Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
被験者募集中
18歳〜75歳 · 全性別 · 2026/06/17更新 · NCT05486572A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
- University of Michigan Rogel Cancer Center, Ann Arbor
- Barbara Ann Karmanos Cancer Institute, Detroit
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/27更新 · NCT05440708A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
- Rogel Comprehensive Cancer Center, Ann Arbor
被験者募集中第2相
18歳以上 · 全性別 · 2026/03/13更新 · NCT05901519A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 129, Detroit
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/11/21更新 · NCT05914116SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Ann Arbor
- Massive Bio SYNERGY-AI site, Lansing
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。